Clinical Research Medical

Curriculum Vitae

Cynthia Brown

**** ******** ***** ************.***@*****.***

St. Joseph, MI 49085 269-***-****

Intention: Experienced Clinical Research Coordinator seeks employment as a

Clinical Research Associate, knowledgeable of Code of Federal Regulations

and ICH guidelines. I aspire to this position because I've mastered the

foundational knowledge required and want to step up to more sophisticated

work. I've proven myself in multiple clinical trial areas, including:

pediatric, adult, infectious disease and family medicine, inpatient and

outpatient. I've done complete trials, from start-up to clinical trial

closure, often doing several simultaneously. I pride myself on rigorous

documentation. I'm an extrovert, able to travel, love people, and I work

hard at quality results and being a team player. Being a CRA is the next

challenge I'd like to take-on.

Employment History

June 1, 2012 - present: Certified Clinical Research Coordinator at

Southwestern Medical Clinic, Lakeland Affiliate. Stevensville, MI

October 2006 -- May, 2012: Home Care Field Nurse for Lakeland Hospital, St.

Joseph Hospital, St. Joseph, MI

May 2001 -- September 2006: Clinical Research for Southwestern Medical

Clinic, working as a subcontractor at Lakeland Hospital, St. Joseph, MI

Education

. Certified Clinical Research Associate, 2003 through ACRP (Association of

Clinical Research Professionals). Still hold this qualification.

. Associate Degree in General Studies, Lake Michigan College, Benton

Harbor, Michigan

. Certificate in Practical Nursing, Lake Michigan College, Benton Harbor,

Michigan

. Basic Life Support Certificate

Interests

Gardening, reading, quilting, baking

Clinical Research (Inpatient Studies)

Safety and Efficacy of Study Drug vs. Comparator in Complicated Skin and

Soft Tissue Infections

Efficacy and Safety of Study Drug in Adult Patients with Early Onset Severe

Sepsis

A Multi-center, Randomized, Double Blind, Comparative Trial of Intravenous

Study Drug vs. Comparator I.V. in the Treatment of Hospitalized Subjects

with Complicated Skin and Skin Structure Infections

Randomized, Open Label, Comparative Study of Study Drug Administered by

Daily 24 hr. Continuous Infusion vs. Study Drug Every 6 Hours for the

Treatment of Hospitalized Patient with Complicated Intra-abdominal

Infections

Study Drug vs. Comparator for the Treatment of Complicated Skin and Soft

Tissue Infections Suspected or Proven to be due to the MR Pathogen

Study Drug vs. Comparator in Complicated Skin/Skin - Structure Infections

Study Drug vs. Comparator Drug in the Treatment of Catheter Related Gram

Positive Bloodstream Infections

Phase IIIB A Randomized, Multi-center, Blinded Study of the Efficacy and

Safety of the Efficacy and Safety of High-Dose, Short Course Study Drug

Therapy in Uncomplicated and Complicated Acute Bacterial Exacerbation of

Chronic Bronchitis

A Randomized, Double blind, Phase III, comparative Study of Study Drug to

Marketed Drug in the Treatment of Moderate to Severe community Acquired

Acute Bacterial Pneumonia due to S. Pneumoniae

Multi-center Randomized study to Compare the Safety and Efficacy of Study

Drug vs. Study Drug in the Treatment of Mild to Severe community Acquired

Pneumonia in Adults

Multi-center, Double Blind, Placebo Controlled, Randomized, Phase 3 Study

of Study Drug in Severe Sepsis

Study Drug vs Marketed Drug in the Treatment of Suspected or Proven

Methicillin-Resistant Staphylococcus Species

Randomized placebo Controlled Trial of Study Drug in Sepsis with Hyper

Inflammatory Response

Double blind Study with Study Drug vs Marketed Drug in the Treatment of

Parties with Nosocomial Pneumonia

Double Blind Study with Study Drug vs. Marketed Drug in the Treatment of

Complicated Skin and Soft Tissue Infections

Double Blind Study with Study Drug vs. Marketed Drug in the Treatment of

Patients with Community Acquired Pneumonia

Double Blind Study with Study Drug vs. Marketed Drug in the Treatment of

Patients with Pelvic Infections

Double Blind Study with Study Drug vs. Marketed Drug in Patients with AECB

Double Blind Placebo Controlled Study in Patients with C. Difficile, Phase

II and III

Randomized, Open Label Study with Study Drug vs. Marketed drug in the

Treatment of Methicillin Resistant Staphylococcal Species

Contact this candidate